Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tinnitus | 5 | 2023 | 197 | 2.660 |
Why?
|
Hearing Loss | 7 | 2023 | 784 | 2.420 |
Why?
|
Cochlear Implants | 11 | 2024 | 342 | 2.370 |
Why?
|
Ear Diseases | 5 | 2022 | 179 | 2.200 |
Why?
|
Otolaryngology | 7 | 2024 | 698 | 2.030 |
Why?
|
Meniere Disease | 3 | 2023 | 164 | 1.970 |
Why?
|
Calcium Channel Blockers | 4 | 2022 | 686 | 1.860 |
Why?
|
Cisplatin | 7 | 2023 | 1658 | 1.770 |
Why?
|
Diltiazem | 4 | 2020 | 132 | 1.770 |
Why?
|
Neuroma, Acoustic | 7 | 2024 | 456 | 1.500 |
Why?
|
Cochlear Implantation | 8 | 2024 | 317 | 1.490 |
Why?
|
Hearing Loss, Sensorineural | 5 | 2023 | 781 | 1.480 |
Why?
|
Vertigo | 8 | 2023 | 204 | 1.290 |
Why?
|
Famous Persons | 2 | 2021 | 108 | 1.210 |
Why?
|
Deafness | 4 | 2024 | 460 | 1.090 |
Why?
|
Otologic Surgical Procedures | 3 | 2016 | 148 | 1.010 |
Why?
|
Eustachian Tube | 2 | 2022 | 99 | 0.850 |
Why?
|
Medical Illustration | 1 | 2024 | 134 | 0.840 |
Why?
|
Music | 2 | 2023 | 249 | 0.830 |
Why?
|
Endolymphatic Sac | 1 | 2023 | 49 | 0.800 |
Why?
|
Cerumen | 1 | 2022 | 7 | 0.800 |
Why?
|
Hearing Loss, Sudden | 1 | 2023 | 44 | 0.800 |
Why?
|
Speech Perception | 6 | 2024 | 512 | 0.750 |
Why?
|
Interdisciplinary Studies | 1 | 2021 | 85 | 0.710 |
Why?
|
Paintings | 1 | 2021 | 101 | 0.690 |
Why?
|
Cinnarizine | 1 | 2020 | 2 | 0.690 |
Why?
|
Dimenhydrinate | 1 | 2020 | 5 | 0.690 |
Why?
|
Sociology | 1 | 2020 | 21 | 0.690 |
Why?
|
Facial Paralysis | 2 | 2021 | 346 | 0.680 |
Why?
|
Microsurgery | 2 | 2024 | 795 | 0.660 |
Why?
|
Cranial Nerves | 1 | 2019 | 95 | 0.640 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2019 | 96 | 0.620 |
Why?
|
Encephalocele | 2 | 2018 | 135 | 0.610 |
Why?
|
Skull Base Neoplasms | 1 | 2022 | 276 | 0.610 |
Why?
|
Chitosan | 1 | 2020 | 138 | 0.610 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2018 | 187 | 0.610 |
Why?
|
Ear, Middle | 2 | 2021 | 341 | 0.600 |
Why?
|
Epiglottitis | 1 | 2017 | 19 | 0.570 |
Why?
|
Gentamicins | 1 | 2018 | 244 | 0.570 |
Why?
|
Dizziness | 6 | 2023 | 269 | 0.570 |
Why?
|
Smell | 1 | 2019 | 259 | 0.560 |
Why?
|
Patient Positioning | 2 | 2022 | 328 | 0.560 |
Why?
|
Mastoiditis | 1 | 2017 | 37 | 0.560 |
Why?
|
History, 19th Century | 4 | 2024 | 711 | 0.550 |
Why?
|
Olfaction Disorders | 1 | 2019 | 223 | 0.550 |
Why?
|
Malleus | 1 | 2016 | 27 | 0.550 |
Why?
|
Hearing Loss, Conductive | 2 | 2021 | 159 | 0.540 |
Why?
|
Antineoplastic Agents | 5 | 2023 | 13648 | 0.540 |
Why?
|
Cochlea | 2 | 2020 | 847 | 0.540 |
Why?
|
Skull Base | 1 | 2019 | 293 | 0.540 |
Why?
|
Hearing Loss, Bilateral | 1 | 2016 | 53 | 0.540 |
Why?
|
Calcium | 2 | 2022 | 5767 | 0.530 |
Why?
|
Meningocele | 1 | 2016 | 50 | 0.520 |
Why?
|
Candida | 1 | 2017 | 172 | 0.510 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2016 | 52 | 0.510 |
Why?
|
Vascular Malformations | 1 | 2021 | 471 | 0.500 |
Why?
|
Facial Nerve Injuries | 1 | 2016 | 64 | 0.500 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2015 | 57 | 0.490 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 187 | 0.480 |
Why?
|
Facial Nerve | 2 | 2020 | 277 | 0.470 |
Why?
|
Vestibule, Labyrinth | 1 | 2016 | 234 | 0.450 |
Why?
|
Candidiasis | 1 | 2017 | 371 | 0.450 |
Why?
|
Tongue | 1 | 2017 | 405 | 0.440 |
Why?
|
Vestibular Diseases | 1 | 2016 | 230 | 0.440 |
Why?
|
Electric Stimulation Therapy | 1 | 2019 | 635 | 0.430 |
Why?
|
Nasal Cavity | 1 | 2015 | 307 | 0.430 |
Why?
|
Nose Neoplasms | 1 | 2015 | 249 | 0.430 |
Why?
|
Semicircular Canals | 1 | 2015 | 203 | 0.420 |
Why?
|
Ear, Inner | 1 | 2017 | 425 | 0.420 |
Why?
|
Vascular Diseases | 1 | 2021 | 1159 | 0.410 |
Why?
|
Neurosurgical Procedures | 1 | 2024 | 2074 | 0.410 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2023 | 1496 | 0.410 |
Why?
|
Migraine Disorders | 2 | 2022 | 1732 | 0.390 |
Why?
|
Antifungal Agents | 1 | 2017 | 769 | 0.380 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2016 | 453 | 0.380 |
Why?
|
Humans | 64 | 2024 | 765968 | 0.370 |
Why?
|
Neck | 1 | 2015 | 733 | 0.360 |
Why?
|
Dexamethasone | 1 | 2018 | 1963 | 0.360 |
Why?
|
Neuropsychological Tests | 2 | 2021 | 7123 | 0.360 |
Why?
|
Length of Stay | 1 | 2024 | 6485 | 0.350 |
Why?
|
Hearing Aids | 3 | 2021 | 58 | 0.330 |
Why?
|
Glucocorticoids | 1 | 2018 | 2132 | 0.320 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 3 | 2020 | 256 | 0.310 |
Why?
|
Bacterial Infections | 1 | 2017 | 1387 | 0.310 |
Why?
|
Mice, Inbred CBA | 3 | 2020 | 439 | 0.310 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2207 | 0.310 |
Why?
|
Tympanic Membrane | 2 | 2022 | 233 | 0.280 |
Why?
|
History, 20th Century | 3 | 2024 | 2761 | 0.280 |
Why?
|
Curriculum | 1 | 2021 | 3782 | 0.280 |
Why?
|
Radiosurgery | 3 | 2020 | 1328 | 0.260 |
Why?
|
Pituitary Neoplasms | 2 | 2024 | 1321 | 0.230 |
Why?
|
Physical Examination | 2 | 2021 | 1266 | 0.230 |
Why?
|
Hearing Tests | 2 | 2021 | 123 | 0.220 |
Why?
|
Pituitary Gland | 2 | 2024 | 631 | 0.220 |
Why?
|
Sphenoid Bone | 1 | 2024 | 176 | 0.210 |
Why?
|
Proteins | 1 | 2017 | 5995 | 0.210 |
Why?
|
Vestibular Neuronitis | 1 | 2022 | 15 | 0.200 |
Why?
|
Nystagmus, Pathologic | 1 | 2023 | 104 | 0.200 |
Why?
|
Noise | 1 | 2024 | 296 | 0.190 |
Why?
|
Maxillary Artery | 1 | 2021 | 18 | 0.190 |
Why?
|
Pituitary Diseases | 1 | 2022 | 136 | 0.190 |
Why?
|
Audiometry, Pure-Tone | 2 | 2021 | 210 | 0.190 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2921 | 0.180 |
Why?
|
Auditory Threshold | 2 | 2019 | 369 | 0.180 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 12976 | 0.180 |
Why?
|
Betahistine | 1 | 2020 | 2 | 0.170 |
Why?
|
Communication Barriers | 1 | 2023 | 418 | 0.170 |
Why?
|
Guinea Pigs | 2 | 2017 | 1300 | 0.160 |
Why?
|
Adult | 17 | 2024 | 223044 | 0.160 |
Why?
|
Sound | 1 | 2020 | 257 | 0.150 |
Why?
|
Subcutaneous Emphysema | 1 | 2018 | 15 | 0.150 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5370 | 0.150 |
Why?
|
Mediastinal Emphysema | 1 | 2018 | 29 | 0.150 |
Why?
|
Free Tissue Flaps | 1 | 2022 | 335 | 0.150 |
Why?
|
Cochlear Nerve | 1 | 2019 | 202 | 0.140 |
Why?
|
Speech Disorders | 1 | 2019 | 178 | 0.140 |
Why?
|
Steroids | 1 | 2023 | 933 | 0.140 |
Why?
|
Physical Therapy Modalities | 1 | 2021 | 533 | 0.140 |
Why?
|
Temporal Bone | 1 | 2022 | 683 | 0.140 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2018 | 86 | 0.140 |
Why?
|
Molecular Motor Proteins | 1 | 2017 | 105 | 0.140 |
Why?
|
Cranial Fossa, Posterior | 1 | 2018 | 134 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9373 | 0.140 |
Why?
|
Retrospective Studies | 13 | 2024 | 81514 | 0.140 |
Why?
|
Language | 2 | 2023 | 1550 | 0.140 |
Why?
|
History, 18th Century | 1 | 2017 | 206 | 0.130 |
Why?
|
Social Isolation | 1 | 2020 | 366 | 0.130 |
Why?
|
Hearing | 1 | 2020 | 505 | 0.130 |
Why?
|
Dilatation | 1 | 2018 | 310 | 0.130 |
Why?
|
Postural Balance | 1 | 2021 | 637 | 0.130 |
Why?
|
Models, Theoretical | 2 | 2019 | 3564 | 0.130 |
Why?
|
Second-Look Surgery | 1 | 2016 | 27 | 0.130 |
Why?
|
Cognition | 3 | 2024 | 7049 | 0.130 |
Why?
|
Government | 1 | 2017 | 161 | 0.130 |
Why?
|
Probability | 1 | 2021 | 2475 | 0.130 |
Why?
|
Hearing Loss, Unilateral | 1 | 2016 | 25 | 0.130 |
Why?
|
Internship and Residency | 1 | 2016 | 5946 | 0.130 |
Why?
|
Acoustic Stimulation | 1 | 2020 | 1255 | 0.130 |
Why?
|
Female | 16 | 2024 | 396112 | 0.120 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 150 | 0.120 |
Why?
|
Nystagmus, Physiologic | 1 | 2015 | 29 | 0.120 |
Why?
|
Drug Carriers | 1 | 2020 | 700 | 0.120 |
Why?
|
Voice Disorders | 1 | 2019 | 286 | 0.120 |
Why?
|
Organ Specificity | 1 | 2020 | 1965 | 0.120 |
Why?
|
Administration, Oral | 1 | 2023 | 4015 | 0.120 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2016 | 119 | 0.120 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18293 | 0.110 |
Why?
|
Hydrogels | 1 | 2020 | 728 | 0.110 |
Why?
|
Speech | 1 | 2019 | 555 | 0.110 |
Why?
|
Neurilemmoma | 1 | 2019 | 522 | 0.110 |
Why?
|
Social Stigma | 1 | 2020 | 788 | 0.100 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26318 | 0.100 |
Why?
|
Treatment Failure | 1 | 2018 | 2652 | 0.100 |
Why?
|
Internet | 1 | 2024 | 3106 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2024 | 15747 | 0.090 |
Why?
|
Treatment Outcome | 6 | 2024 | 65188 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1574 | 0.090 |
Why?
|
Child | 5 | 2023 | 80564 | 0.080 |
Why?
|
Male | 13 | 2024 | 363698 | 0.080 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1069 | 0.080 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7838 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2140 | 0.080 |
Why?
|
Animals | 6 | 2020 | 168764 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10383 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2822 | 0.080 |
Why?
|
Aged | 9 | 2024 | 171117 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6499 | 0.070 |
Why?
|
Primary Health Care | 2 | 2021 | 4736 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2887 | 0.070 |
Why?
|
Databases, Factual | 1 | 2023 | 8067 | 0.070 |
Why?
|
Electroencephalography | 1 | 2023 | 6273 | 0.070 |
Why?
|
United States | 5 | 2024 | 72903 | 0.070 |
Why?
|
Immunotherapy | 1 | 2023 | 4752 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3278 | 0.070 |
Why?
|
Prevalence | 1 | 2023 | 15842 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5508 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2020 | 12437 | 0.060 |
Why?
|
Quality of Life | 3 | 2022 | 13462 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20659 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3454 | 0.060 |
Why?
|
Middle Aged | 8 | 2024 | 223009 | 0.050 |
Why?
|
Mice | 3 | 2020 | 81819 | 0.050 |
Why?
|
Sella Turcica | 1 | 2022 | 117 | 0.050 |
Why?
|
Caloric Tests | 1 | 2021 | 10 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3835 | 0.050 |
Why?
|
Hydroxyapatites | 1 | 2021 | 73 | 0.050 |
Why?
|
Thigh | 1 | 2022 | 238 | 0.050 |
Why?
|
Apoptosis | 1 | 2017 | 9514 | 0.050 |
Why?
|
Vestibular Function Tests | 1 | 2021 | 128 | 0.050 |
Why?
|
Audiometry | 1 | 2021 | 253 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74840 | 0.040 |
Why?
|
Durapatite | 1 | 2021 | 166 | 0.040 |
Why?
|
Mouth | 1 | 2022 | 381 | 0.040 |
Why?
|
Bone Cements | 1 | 2021 | 318 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 41649 | 0.040 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7875 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 36532 | 0.040 |
Why?
|
Speech Production Measurement | 1 | 2019 | 100 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7478 | 0.040 |
Why?
|
Sensation Disorders | 1 | 2019 | 160 | 0.040 |
Why?
|
Young Adult | 2 | 2022 | 59889 | 0.040 |
Why?
|
Speech Acoustics | 1 | 2019 | 155 | 0.040 |
Why?
|
Frontal Bone | 1 | 2018 | 105 | 0.040 |
Why?
|
Hair Cells, Auditory, Outer | 1 | 2017 | 98 | 0.030 |
Why?
|
Voice Quality | 1 | 2019 | 226 | 0.030 |
Why?
|
Electrodes, Implanted | 1 | 2020 | 830 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2021 | 1191 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 54802 | 0.030 |
Why?
|
Headache | 1 | 2023 | 1259 | 0.030 |
Why?
|
Infant | 1 | 2017 | 36386 | 0.030 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2018 | 325 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 1880 | 0.030 |
Why?
|
Species Specificity | 1 | 2017 | 2406 | 0.030 |
Why?
|
Reoperation | 1 | 2021 | 4294 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3475 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1772 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12056 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59489 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14751 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15880 | 0.010 |
Why?
|
Medicare | 1 | 2021 | 6823 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21480 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88835 | 0.010 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_